Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

WINNERS & LOSERS: Energy stocks up; Wise gains on growth update

13th Apr 2026 11:49

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday.

----------

Main Market small-cap winners

----------

BSF Enterprise PLC, up 31% at 2.12 pence

abrdn Property Income Trust Ltd, up 30% at 2.27p

Wildcat Petroleum PLC, up 25% at 0.06p, as Brent oil rises 9.1% to USD102.90 per barrel

Bluebird Mining Ventures Ltd, up 18% at 0.10p

Kosmos Energy Ltd, up 13% at 206.00p, as Brent oil rises 9.1% to USD102.90 per barrel

----------

Main Market small-cap losers

----------

Plaza Centers NV, down 36% at 14.50p

Technology Minerals PLC, down 17% at 0.075p

Gem Diamonds Ltd, down 12% at 3.79p

ICFG Ltd, down 12% at 15.00p

Abrdn European Logistics Income PLC, down 9.3% at 25.17p

----------

AIM winners

----------

Mercantile Ports & Logistics Ltd, up 68% at 2.6 pence

Thalia Therapeutics PLC, up 67% at 0.75p

Trellus Health, up 50% at 0.30p, on renewal of licensing deal with Pfizer

PipeHawk PLC, up 43% at 2.50p

t42 IoT Tracking Solutions PLC, up 36% at 4.55p, on higher annual earnings

----------

AIM losers

----------

Mothercare PLC, down 31% at 1.10p, following pre-close trading update

Directa Plus PLC, down 18% at 5.50p, shares suspended on funding uncertainty

CML Microsystems PLC, down 8.9% at 225.00p

Coiled Therapeutics PLC, down 8.3% at 8.25p

Empyrean Energy PLC, down 8.3% at 0.05p

----------

Small-cap and AIM movers in focus:

----------

t42 IoT Tracking Solutions PLC, up 36% at 4.55 pence, 12-month range 1.64p-5.18p. Reports strong 2025 growth, driven by a surge in container-related sales. Revenue rises to USD6.1 million from USD4.2 million, with container-related sales up more than 250% year-on-year. Total comprehensive loss narrows to USD576,000 from USD1.7 million, despite a higher cost of revenue. Separately, signs a distribution partnership with Relegen covering Australia and New Zealand to support product development and deployment in Australasia.

----------

Mothercare PLC, down 31% at 1.10 pence, 12-month range 0.95p-4.00p. Reports lower earnings and sales in financial 2026, amid ongoing Middle East uncertainty. The Watford, England-based retailer which specialises in products for newborn babies and children says adjusted Ebitda falls to GBP1.3 million from GBP3.5 million, while worldwide retail sales by franchise partners decline 22% to GBP180 million. Says the Middle East conflict has a GBP100,000 impact, noting continued uncertainty for franchise partners in the region, though recent performance has been "usefully resilient" ahead of financial 2027.

----------

Directa Plus PLC, last quoted at 5.50 pence, 12-month range 5.5p-22p. Shares suspended from trading on AIM with immediate effect. The graphene product maker based in Lomazzo, Italy, says it may enter administration if additional funding is not secured, and will engage corporate restructuring advisers to protect stakeholders. It adds that its Italian subsidiary will continue operating until liquidation.

----------

Wise PLC, up 5.6% at 1,026.00 pence, 12-month range 793.00p-1,225.00p. Reports strong growth in volumes and income, and updates reporting ahead of planned US listing. The London-based money transfer services provider says quarterly cross-border volumes rise 26% to GBP49.4 billion, with active customers up 22% to 11.3 million. Underlying income grows 24% to GBP435.3 million. For the full year, volumes increase 25% to GBP181.7 billion and underlying income rises 18% to GBP1.61 billion, with margins expected at the top end of guidance. Says it will switch to US GAAP and dollar reporting as part of its planned dual listing, citing benefits from greater US market visibility and access to capital.

----------

Trellus Health, up 50% at 0.30 pence, 12-month range 0.15p-2.34p. Renews licensing agreement with Pfizer Inc for patient support content. Says Pfizer will continue to use its educational materials within an inflammatory bowel disease digital application, extending a partnership first signed in the second quarter of 2024. Trellus Health Chief Executive Officer Marla Dubinsky said: "We are excited to extend this agreement with Pfizer, which underscores both the continued engagement of their users with our content on the platform and the value of our resilience-driven approach and methodology."

----------

By Eva Castanedo, Alliance News reporter

Comments and questions to [email protected]

Copyright 2026 Alliance News Ltd. All Rights Reserved.


Related Shares:

PlazaTech MineralsGem Diamonds DiIcfg LimitedAbrdn Euro LogBio-Sustainable Future EnterprisesAbrdn PropertyBluebird Mining VenturesWildcat Petrol.Kosmos EnergyMercantile Ports & LogisticsThalia Therap.PipeHawkT42 Iot Track.MothercareCoiled TheraCML MicrocircuitsDirecta PlusEmpyreanWise PlcTrellus Health.
FTSE 100 Latest
Value10,556.70
Change-43.83